Korean Journal of Radiology

  • 제20권4호
  • /
  • Pages.533-541
  • /
  • 2019
  • /
  • 1229-6929(pISSN)
  • /
  • 2005-8330(eISSN)
대한영상의학회 (The Korean Society of Radiology)
권호 표지
DOI QR코드

DOI QR Code

Abbreviated Magnetic Resonance Imaging for Breast Cancer Screening: Concept, Early Results, and Considerations

  • Eun Sook Ko (Department of Radiology, Breast Imaging Service, Memorial Sloan-Kettering Cancer Center) ;
  • Elizabeth A. Morris (Department of Radiology, Breast Imaging Service, Memorial Sloan-Kettering Cancer Center)
  • 투고 : 2018.10.16
  • 심사 : 2018.12.27
  • 발행 : 2019.04.01
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Breast magnetic resonance imaging (MRI) has been increasingly utilized, especially in screening for high-risk cases, because of its high sensitivity and superior ability to detect cancers as compared with mammography and ultrasound. Several limitations such as higher cost, longer examination time, longer interpretation time, and low availability have hindered the wider application of MRI, especially for screening of average-risk women. To overcome some of these limitations and increase access to MRI screening, an abbreviated breast MRI protocol has been introduced. Abbreviated breast MRI is becoming popular and challenges the status quo. This review aims to present an overview of abbreviated MRI, discuss the current findings, and introduce ongoing prospective trials.

키워드

참고문헌

  1. de Koning HJ. Mammographic screening: evidence from randomized controlled trials. Ann Oncol 2003;14:1185-1189  https://doi.org/10.1093/annonc/mdg319
  2. Tabar L, Yen MF, Vitak B, Chen HH, Smith RA, Duffy SW. Mammography service screening and mortality in breast cancer patients: 20-year follow-up before and after introduction of screening. Lancet 2003;361:1405-1410  https://doi.org/10.1016/S0140-6736(03)13143-1
  3. Nelson HD, Cantor A, Humphrey L, Fu R, Pappas M, Daeges M, et al. Screening for breast cancer: a systematic review to update the 2009 U.S. preventive services task force recommendation [Internet]. Report No. 14-05201-EF-1. Rockville, MD: Agency for Healthcare Research and Quality (US), 2016 
  4. Lauby-Secretan B, Scoccianti C, Loomis D, Benbrahim-Tallaa L, Bouvard V, Bianchini F, et al. Breast-cancer screening: viewpoint of the IARC Working Group. N Engl J Med 2015;372:2353-2358  https://doi.org/10.1056/NEJMsr1504363
  5. Feig S. Cost-effectiveness of mammography, MRI, and ultrasonography for breast cancer screening. Radiol Clin North Am 2010;48:879-891  https://doi.org/10.1016/j.rcl.2010.06.002
  6. Mandelson MT, Oestreicher N, Porter PL, White D, Finder CA, Taplin SH, et al. Breast density as a predictor of mammographic detection: comparison of interval- and screen-detected cancers. J Natl Cancer Inst 2000;92:1081-1087  https://doi.org/10.1093/jnci/92.13.1081
  7. Crystal P, Strano SD, Shcharynski S, Koretz MJ. Using sonography to screen women with mammographically dense breasts. AJR Am J Roentgenol 2003;181:177-182  https://doi.org/10.2214/ajr.181.1.1810177
  8. Kerlikowske K, Grady D, Barclay J, Sickles EA, Ernster V. Effect of age, breast density, and family history on the sensitivity of first screening mammography. JAMA 1996;276:33-38  https://doi.org/10.1001/jama.1996.03540010035027
  9. Buist DS, Porter PL, Lehman C, Taplin SH, White E. Factors contributing to mammography failure in women aged 40-49 years. J Natl Cancer Inst 2004;96:1432-1440  https://doi.org/10.1093/jnci/djh269
  10. Fletcher SW, Elmore JG. Clinical practice. Mammographic screening for breast cancer. N Engl J Med 2003;348:1672-1680  https://doi.org/10.1056/NEJMcp021804
  11. Price ER, Hargreaves J, Lipson JA, Sickles EA, Brenner RJ, Lindfors KK, et al. The California breast density information group: a collaborative response to the issues of breast density, breast cancer risk, and breast density notification legislation. Radiology 2013;269:887-892  https://doi.org/10.1148/radiol.13131217
  12. Berg WA, Blume JD, Cormack JB, Mendelson EB, Lehrer D, Bohm-Velez M, et al. Combined screening with ultrasound and mammography vs mammography alone in women at elevated risk of breast cancer. JAMA 2008;299:2151-2163  https://doi.org/10.1001/jama.299.18.2151
  13. Hooley RJ, Greenberg KL, Stackhouse RM, Geisel JL, Butler RS, Philpotts LE. Screening US in patients with mammographically dense breasts: initial experience with Connecticut Public Act 09-41. Radiology 2012;265:59-69  https://doi.org/10.1148/radiol.12120621
  14. Weigert J, Steenbergen S. The Connecticut experiments second year: ultrasound in the screening of women with dense breasts. Breast J 2015;21:175-180  https://doi.org/10.1111/tbj.12386
  15. Sardanelli F, Podo F, Santoro F, Manoukian S, Bergonzi S, Trecate G, et al. Multicenter surveillance of women at high genetic breast cancer risk using mammography, ultrasonography, and contrast-enhanced magnetic resonance imaging (the high breast cancer risk italian 1 study): final results. Invest Radiol 2011;46:94-105  https://doi.org/10.1097/RLI.0b013e3181f3fcdf
  16. Kuhl C, Weigel S, Schrading S, Arand B, Bieling H, Konig R, et al. Prospective multicenter cohort study to refine management recommendations for women at elevated familial risk of breast cancer: the EVA trial. J Clin Oncol 2010;28:1450-1457  https://doi.org/10.1200/JCO.2009.23.0839
  17. Lehman CD, Lee JM, DeMartini WB, Hippe DS, Rendi MH, Kalish G, et al. Screening MRI in women with a personal history of breast cancer. J Natl Cancer Inst 2016;7:108 
  18. Kuhl CK, Schrading S, Leutner CC, Morakkabati-Spitz N, Wardelmann E, Fimmers R, et al. Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer. J Clin Oncol 2005;23:8469-8476  https://doi.org/10.1200/JCO.2004.00.4960
  19. Leach MO, Boggis CR, Dixon AK, Easton DF, Eeles RA, Evans DG, et al. Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS). Lancet 2005;365:1769-1778  https://doi.org/10.1016/S0140-6736(05)66481-1
  20. Warner E, Plewes DB, Hill KA, Causer PA, Zubovits JT, Jong RA, et al. Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination. JAMA 2004;292:1317-1325  https://doi.org/10.1001/jama.292.11.1317
  21. Morris EA, Liberman L, Ballon DJ, Robson M, Abramson AF, Heerdt A, et al. MRI of occult breast carcinoma in a high-risk population. AJR Am J Roentgenol 2003;181:619-626  https://doi.org/10.2214/ajr.181.3.1810619
  22. Vreemann S, Gubern-Merida A, Schlooz-Vries MS, Bult P, van Gils CH, Hoogerbrugge N, et al. Influence of risk category and screening round on the performance of an MR imaging and mammography screening program in carriers of the BRCA mutation and other women at increased risk. Radiology 2018;286:443-451  https://doi.org/10.1148/radiol.2017170458
  23. European guidelines for quality assurance in breast cancer screening and diagnosis. Available at: http://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=1&ved=2ahUKEwiMlNy6vNbdAhWihOAKHU3PAdsQFjAAegQIChAC&url=http%3A%2F%2Fwww.euref.org%2Fdownloads%3Fdownload%3D24%3Aeuropean-guidelines-for-quality-assurance-in-breast-cancer-screening-and-diagnosis-pdf&usg=AOvVaw33H5VVb-pU7xQuLzzO8KcM. Accessed August 24, 2018 
  24. Kuhl CK, Strobel K, Bieling H, Leutner C, Schild HH, Schrading S. Supplemental breast MR imaging screening of women with average risk of breast cancer. Radiology 2017;283:361-370  https://doi.org/10.1148/radiol.2016161444
  25. Sung JS, Stamler S, Brooks J, Kaplan J, Huang T, Dershaw DD, et al. Breast cancers detected at screening MR imaging and mammography in patients at high risk: method of detection reflects tumor histopathologic results. Radiology 2016;280:716-722  https://doi.org/10.1148/radiol.2016151419
  26. American College of Radiology. ACR practice parameter for the performance of contrast-enhanced magnetic resonance imaging (MRI) of the breast. Resolution 34. Available at: https://www.acr.org/-/media/ACR/Files/Practice-Parameters/mr-contrast-breast.pdf. Revised 2018. Accessed September 25, 2018 
  27. Saslow D, Boetes C, Burke W, Harms S, Leach MO, Lehman CD, et al. American Cancer Society guidelines for breast screening with MRI as an adjunct mammography. CA Cancer J Clin 2007;57:75-89  https://doi.org/10.3322/canjclin.57.2.75
  28. Plevritis SK, Kurian AW, Sigal BM, Daniel BL, Ikeda DM, Stockdale FE, et al. Cost-effectiveness of screening BRCA1/2 mutation carriers with breast magnetic resonance imaging. JAMA 2006;295:2374-2384  https://doi.org/10.1001/jama.295.20.2374
  29. Taneja C, Edelsberg J, Weycker D, Guo A, Oster G, Weinreb J. Cost effectiveness of breast cancer screening with contrast-enhanced MRI in high-risk women. J Am Coll Radiol 2009;6:171-179  https://doi.org/10.1016/j.jacr.2008.10.003
  30. Kriege M, Brekelmans CT, Boetes C, Besnard PE, Zonderland HM, Obdeijn IM, et al. Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. N Engl J Med 2004;351:427-437  https://doi.org/10.1056/NEJMoa031759
  31. Brennan S, Liberman L, Dershaw DD, Morris E. Breast MRI screening of women with a personal history of breast cancer. AJR Am J Roentgenol 2010;195:510-516  https://doi.org/10.2214/AJR.09.3573
  32. Schacht DV, Yamaguchi K, Lai J, Kulkarni K, Sennett CA, Abe H. Importance of a personal history of breast cancer as a risk factor for the development of subsequent breast cancer: results from screening breast MRI. AJR Am J Roentgenol 2014;202:289-292  https://doi.org/10.2214/AJR.13.11553
  33. Destounis S, Arieno A, Morgan R. Personal history of premenopausal breast cancer as a risk factor for referral to screening breast MRI. Acad Radiol 2016;23:353-357  https://doi.org/10.1016/j.acra.2015.11.012
  34. Kuhl CK, Schrading S, Strobel K, Schild HH, Hilgers RD, Bieling HB. Abbreviated breast magnetic resonance imaging (MRI): first postcontrast subtracted images and maximum-intensity projection-a novel approach to breast cancer screening with MRI. J Clin Oncol 2014;32:2304-2310  https://doi.org/10.1200/JCO.2013.52.5386
  35. Heacock L, Melsaether AN, Heller SL, Gao Y, Pysarenko KM, Babb JS, et al. Evaluation of a known breast cancer using an abbreviated breast MRI protocol: correlation of imaging characteristics and pathology with lesion detection and conspicuity. Eur J Radiol 2016;85:815-823  https://doi.org/10.1016/j.ejrad.2016.01.005
  36. Mango VL, Morris EA, David Dershaw D, Abramson A, Fry C, Moskowitz CS, et al. Abbreviated protocol for breast MRI: are multiple sequences needed for cancer detection? Eur J Radiol 2015;84:65-70  https://doi.org/10.1016/j.ejrad.2014.10.004
  37. Grimm LJ, Soo MS, Yoon S, Kim C, Ghate SV, Johnson KS. Abbreviated screening protocol for breast MRI: a feasibility study. Acad Radiol 2015;22:1157-1162  https://doi.org/10.1016/j.acra.2015.06.004
  38. Moschetta M, Telegrafo M, Rella L, Stabile Ianora AA, Angelelli G. Abbreviated combined MR protocol: a new faster strategy for characterizing breast lesions. Clin Breast Cancer 2016;16:207-211  https://doi.org/10.1016/j.clbc.2016.02.008
  39. Harvey SC, Di Carlo PA, Lee B, Obadina E, Sippo D, Mullen L. An abbreviated protocol for high-risk screening breast MRI saves time and resources. J Am Coll Radiol 2016;13:374-380  https://doi.org/10.1016/j.jacr.2015.08.015
  40. Chen SQ, Huang M, Shen YY, Liu CL, Xu CX. Abbreviated MRI protocols for detecting breast cancer in women with dense breasts. Korean J Radiol 2017;18:470-475  https://doi.org/10.3348/kjr.2017.18.3.470
  41. Kuhl C. The current status of breast MR imaging. Part I. Choice of technique, image interpretation, diagnostic accuracy, and transfer to clinical practice. Radiology 2007;244:356-378  https://doi.org/10.1148/radiol.2442051620
  42. Mann RM, Kuhl CK, Kinkel K, Boetes C. Breast MRI: guidelines from the European Society of Breast Imaging. Eur Radiol 2008;18:1307-1318  https://doi.org/10.1007/s00330-008-0863-7
  43. Garg AS, Rapelyea JA, Rechtman LR, Torrente J, Bittner RB, Coffey CM, et al. Full-field digital mammographic interpretation with prior analog versus prior digitized analog mammography: time for interpretation. AJR Am J Roentgenol 2011;196:1436-1438  https://doi.org/10.2214/AJR.10.5430
  44. Tchou PM, Haygood TM, Atkinson EN, Stephens TW, Davis PL, Arribas EM, et al. Interpretation time of computer-aided detection at screening mammography. Radiology 2010;257:40-46  https://doi.org/10.1148/radiol.10092170
  45. Lehman CD, Blume JD, DeMartini WB, Hylton NM, Herman B, Schnall MD. Accuracy and interpretation time of computer-aided detection among novice and experienced breast MRI readers. AJR Am J Roentgenol 2013;200:W683-W689  https://doi.org/10.2214/AJR.11.8394
  46. Partridge SC, Stone KM, Strigel RM, DeMartini WB, Peacock S, Lehman CD. Breast DCE-MRI: influence of postcontrast timing on automated lesion kinetics assessments and discrimination of benign and malignant lesions. Acad Radiol 2014;21:1195-1203  https://doi.org/10.1016/j.acra.2014.04.013
  47. Oldrini G, Fedida B, Poujol J, Felblinger J, Trop I, Henrot P, et al. Abbreviated breast magnetic resonance protocol: value of high-resolution temporal dynamic sequence to improve lesion characterization. Eur J Radiol 2017;95:177-185  https://doi.org/10.1016/j.ejrad.2017.07.025
  48. DeMartini WB, Liu F, Peacock S, Eby PR, Gutierrez RL, Lehman CD. Background parenchymal enhancement on breast MRI: impact on diagnostic performance. AJR Am J Roentgenol 2012;198:W373-W380  https://doi.org/10.2214/AJR.10.6272
  49. Kuhl CK, Bieling HB, Gieseke J, Kreft BP, Sommer T, Lutterbey G, et al. Healthy premenopausal breast parenchyma in dynamic contrast-enhanced MR imaging of the breast: normal contrast medium enhancement and cyclical-phase dependency. Radiology 1997;203:137-144  https://doi.org/10.1148/radiology.203.1.9122382
  50. Ellis RL. Optimal timing of breast MRI examinations for premenopausal women who do not have a normal menstrual cycle. AJR Am J Roentgenol 2009;193:1738-1740  https://doi.org/10.2214/AJR.09.2657
  51. Amarosa AR, McKellop J, Klautau Leite AP, Moccaldi M, Clendenen TV, Babb JS, et al. Evaluation of the kinetic properties of background parenchymal enhancement throughout the phase of the menstrual cycle. Radiology 2013;268;356-365  https://doi.org/10.1148/radiol.13121101
  52. McDonald RJ, McDonald JS, Kallmes DF, Jentoft ME, Murray DL, Thielen KR, et al. Intracranial gadolinium deposition after contrast-enhanced MR imaging. Radiology 2015;275:772-782  https://doi.org/10.1148/radiol.15150025
  53. McDonald RJ, McDonald JS, Dai D, Schroeder D, Jentoft ME, Murray DL, et al. Comparison of gadolinium concentrations within multiple rat organs after intravenous administration of linear versus macrocyclic gadolinium chelates. Radiology 2017;285:536-545  https://doi.org/10.1148/radiol.2017161594
  54. American College of Radiology, Committee on Drugs and Contrast Media. ACR Manual on contrast media, Version 10.1. Reston, VA: American College of Radiology, 2015